Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant |
---|---|
Disease/Condition | Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Nicole Nevadunsky, MD |
Contact Name | Meghan Proehl |
Contact Email | mproehl@montefiore.org |
Protocol Number | 2018-9873 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Cancer-Related Ovary |
Adult, Pediatric, Both | Adult |